Transaction Details

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 27, 2024. | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $129.21 to $129.94, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. | 66,873 options were granted on February 6, 2019, and vested and became exercisable ratably in four installments on each anniversary of February 6, 2019. Prior to the transactions reported on this Form 4,55,728 of these options that remain outstanding had vested.